Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.
Department of Epidemiology, Institute for Pharmacological Research 'Mario Negri', Milan; Department of Preclinical and Clinical Pharmacology 'Mario Aiazzi Mancini', University of Florence, Florence, Italy.
Ann Oncol. 2012 Nov;23(11):2964-2970. doi: 10.1093/annonc/mds140. Epub 2012 Jul 5.
Pancreatitis is a known risk factor for pancreatic cancer; however, an unknown fraction of the disease is thought to be a consequence of tumor-related duct obstruction.
A pooled analysis of a history of pancreatitis and risk of pancreatic cancer was carried out considering the time interval between diagnoses and potential modification by covariates. Adjusted pooled odds ratios (ORs) and 95% confidence intervals (CIs) were estimated from 10 case-control studies (5048 cases of ductal pancreatic adenocarcinoma and 10,947 controls) taking part in the International Pancreatic Cancer Case-Control Consortium (PanC4).
The association between pancreatitis and pancreatic cancer was nearly three-fold at intervals of >2 years between diagnoses (OR: 2.71, 95% CI: 1.96-3.74) and much stronger at intervals of ≤2 years (OR: 13.56, 95% CI: 8.72-21.90) probably reflecting a combination of reverse causation and antecedent misdiagnosis of pancreas cancer as pancreatitis. The younger (<65 years) pancreatic cancer cases showed stronger associations with previous (>2 years) pancreatitis (OR: 3.91, 95% CI: 2.53-6.04) than the older (≥65 years) cases (OR: 1.68, 95% CI: 1.02-2.76; P value for interaction: 0.006).
Despite a moderately strong association between pancreatitis (diagnosed before >2 years) and pancreatic cancer, the population attributable fraction was estimated at 1.34% (95% CI: 0.612-2.07%), suggesting that a relatively small proportion of pancreatic cancer might be avoided if pancreatitis could be prevented.
胰腺炎是胰腺癌的已知危险因素;然而,据认为,这种疾病的未知部分是肿瘤相关的胆管阻塞的结果。
考虑到诊断之间的时间间隔以及协变量的潜在修饰作用,对胰腺炎病史和胰腺癌风险进行了汇总分析。来自参与国际胰腺癌症病例对照研究联盟(PanC4)的 10 项病例对照研究(5048 例导管腺癌和 10947 例对照)的数据,采用调整后的合并比值比(OR)和 95%置信区间(CI)进行了估计。
胰腺炎与胰腺癌之间的关联在诊断间隔>2 年时接近三倍(OR:2.71,95%CI:1.96-3.74),在诊断间隔≤2 年时更强(OR:13.56,95%CI:8.72-21.90),可能反映了反向因果关系和先前对胰腺癌的误诊的综合影响。年轻(<65 岁)的胰腺癌病例与先前(>2 年)胰腺炎的关联更强(OR:3.91,95%CI:2.53-6.04),而年龄较大(≥65 岁)的病例则较弱(OR:1.68,95%CI:1.02-2.76;交互作用检验 P 值:0.006)。
尽管胰腺炎(诊断前>2 年)与胰腺癌之间存在中度强关联,但人群归因分数估计为 1.34%(95%CI:0.612-2.07%),这表明如果能够预防胰腺炎,可能会避免相对较小比例的胰腺癌。